The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent

233Citations
Citations of this article
212Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The opportunistic pathogen Pseudomonas aeruginosa causes infections that are difficult to treat by antibiotic therapy. This bacterium can cause biofilm infections where it shows tolerance to antibiotics. Here we report the novel use of a metallo-complex, desferrioxamine-gallium (DFO-Ga) that targets P. aeruginosa iron metabolism. This complex kills free-living bacteria and blocks biofilm formation. A combination of DFO-Ga and the anti-Pseudomonas antibiotic gentamicin caused massive killing of P. aeruginosa cells in mature biofilms. In a P. aeruginosa rabbit corneal infection, topical administration of DFO-Ga together with gentamicin decreased both infiltrate and final scar size by about 50% compared to topical application of gentamicin alone. The use of DFO-Ga as a Trojan horse delivery system that interferes with iron metabolism shows promise as a treatment for P. aeruginosa infections. © 2008 by The National Academy of Sciences of the USA.

Cite

CITATION STYLE

APA

Banin, E., Lozinski, A., Brady, K. M., Berenshtein, E., Butterfield, P. W., Moshe, M., … Banin, E. (2008). The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent. Proceedings of the National Academy of Sciences of the United States of America, 105(43), 16761–16766. https://doi.org/10.1073/pnas.0808608105

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free